{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:06:36Z","timestamp":1776668796129,"version":"3.51.2"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2024JJ9307"],"award-info":[{"award-number":["2024JJ9307"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Key Program of Guangxi Natural Science Foundation","award":["2023GXNSFDA026010"],"award-info":[{"award-number":["2023GXNSFDA026010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-05683-2","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T10:04:38Z","timestamp":1772877878000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative predictive value of three non-insulin-based insulin resistance indices for subclinical left ventricular dysfunction in type 2 diabetes mellitus"],"prefix":"10.1186","volume":"26","author":[{"given":"Xin","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiping","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"key":"5683_CR1","doi-asserted-by":"publisher","unstructured":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021. Lancet (london, England). 2023;402(10397):203\u2013234. https:\/\/doi.org\/10.1016\/S0140-6736(23)01301-6.","DOI":"10.1016\/S0140-6736(23)01301-6"},{"issue":"10","key":"5683_CR2","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41569-023-00877-z","volume":"20","author":"ND Wong","year":"2023","unstructured":"Wong ND, Sattar N. Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention. Nat Rev Cardiol. 2023;20(10):685\u201395. https:\/\/doi.org\/10.1038\/s41569-023-00877-z.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"5683_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","volume":"61","author":"G Jia","year":"2018","unstructured":"Jia G, Whaley-Connell A, Sowers JR. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia. 2018;61(1):21\u20138. https:\/\/doi.org\/10.1007\/s00125-017-4390-4.","journal-title":"Diabetologia"},{"key":"5683_CR4","doi-asserted-by":"publisher","first-page":"746382","DOI":"10.3389\/fcvm.2021.746382","volume":"8","author":"M Mohan","year":"2021","unstructured":"Mohan M, Dihoum A, Mordi IR, et al. Left ventricular hypertrophy in diabetic cardiomyopathy: a target for intervention. Front Cardiovasc Med. 2021;8:746382. https:\/\/doi.org\/10.3389\/fcvm.2021.746382.","journal-title":"Front Cardiovasc Med"},{"key":"5683_CR5","doi-asserted-by":"publisher","first-page":"1048675","DOI":"10.3389\/fnut.2023.1048675","volume":"10","author":"Z Ghorbani","year":"2023","unstructured":"Ghorbani Z, Mirmohammadali SN, Shoaibinobarian N, et al. Insulin resistance surrogate markers and risk of hyperuricemia among patients with and without coronary artery disease: a cross-sectional study. Front Nutr. 2023;10:1048675. https:\/\/doi.org\/10.3389\/fnut.2023.1048675.","journal-title":"Front Nutr"},{"key":"5683_CR6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12933-024-02334-8","volume":"23","author":"M Duan","year":"2024","unstructured":"Duan M, Zhao X, Li S, et al. Metabolic score for insulin resistance (METS-IR) predicts all-cause and cardiovascular mortality in the general population: evidence from NHANES 2001\u20132018. Cardiovasc Diabetol. 2024;23:243. https:\/\/doi.org\/10.1186\/s12933-024-02334-8.","journal-title":"Cardiovasc Diabetol"},{"key":"5683_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12933-025-02618-7","volume":"24","author":"L Jiang","year":"2025","unstructured":"Jiang L, Zhu T, Song W, et al. Assessment of six insulin resistance surrogate indexes for predicting stroke incidence in Chinese middle-aged and elderly populations with abnormal glucose metabolism: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24:56. https:\/\/doi.org\/10.1186\/s12933-025-02618-7.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"5683_CR8","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/jdi.14026","volume":"14","author":"Q Sun","year":"2023","unstructured":"Sun Q, Liu J, Meng R, et al. Association of the triglyceride\u2010glucose index with subclinical left ventricular dysfunction in\u00a0type\u20092 diabetes mellitus patients: a\u00a0retrospective cross\u2010sectional study. J Diabetes Investig. 2023;14(8):953\u201360. https:\/\/doi.org\/10.1111\/jdi.14026.","journal-title":"J Diabetes Investig"},{"issue":"4","key":"5683_CR9","first-page":"315","volume":"13","author":"Chinese Society of Endocrinology, Chinese Medical Association","year":"2021","unstructured":"Chinese Society of Endocrinology, Chinese Medical Association. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition)[J]. Chin J Diabetes Mellitus. 2021;13(4):315\u2013409.","journal-title":"Chin J Diabetes Mellitus"},{"key":"5683_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12944-023-01796-1","volume":"22","author":"Y Chen","year":"2023","unstructured":"Chen Y, Fu J, Wang Y, et al. Association between triglyceride glucose index and subclinical left ventricular systolic dysfunction in patients with type 2 diabetes. Lipids Health Dis. 2023;22:35. https:\/\/doi.org\/10.1186\/s12944-023-01796-1.","journal-title":"Lipids Health Dis"},{"issue":"8","key":"5683_CR11","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1097\/HJH.0000000000003761","volume":"42","author":"E Gherbesi","year":"2024","unstructured":"Gherbesi E, Faggiano A, Sala C, et al. Left ventricular systolic dysfunction in obesity: a meta-analysis of speckle tracking echocardiographic studies. J Hypertens. 2024;42(8):1449\u201359. https:\/\/doi.org\/10.1097\/HJH.0000000000003761.","journal-title":"J Hypertens"},{"issue":"3","key":"5683_CR12","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jcmg.2024.07.011","volume":"18","author":"OA Smiseth","year":"2025","unstructured":"Smiseth OA, Rider O, Cvijic M, et al. Myocardial strain imaging: theory, current practice, and the future. JACC Cardiovasc Imaging. 2025;18(3):340\u201381. https:\/\/doi.org\/10.1016\/j.jcmg.2024.07.011.","journal-title":"JACC Cardiovasc Imaging"},{"key":"5683_CR13","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12933-021-01404-5","volume":"20","author":"S Todo","year":"2021","unstructured":"Todo S, Tanaka H, Yamauchi Y, et al. Association of left ventricular longitudinal myocardial function with subclinical right ventricular dysfunction in type 2 diabetes mellitus. Cardiovasc Diabetol. 2021;20:212. https:\/\/doi.org\/10.1186\/s12933-021-01404-5.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"5683_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4093\/dmj.2021.0280","volume":"46","author":"SH Lee","year":"2022","unstructured":"Lee SH, Park SY, Choi CS. Insulin resistance: from mechanisms to therapeutic strategies. Diabetes Metab J. 2022;46(1):15\u201337. https:\/\/doi.org\/10.4093\/dmj.2021.0280.","journal-title":"Diabetes Metab J"},{"key":"5683_CR15","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee. 8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2024[J]. Diabetes Care. 2024;47(Suppl 1):S145-S157. https:\/\/doi.org\/10.2337\/dc24-S008.","DOI":"10.2337\/dc24-S008"},{"issue":"Supp 1","key":"5683_CR16","doi-asserted-by":"publisher","first-page":"S179","DOI":"10.2337\/dc24-S010","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","unstructured":"American Diabetes Association Professional Practice Committee. Cardiovascular disease and risk management: standards of care in diabetes-2024[J]. Diabetes Care. 2024;47(Supp 1):S179\u2013218. https:\/\/doi.org\/10.2337\/dc24-S010.","journal-title":"Diabetes Care"},{"key":"5683_CR17","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s12933-024-02446-1","volume":"23","author":"S Tao","year":"2024","unstructured":"Tao S, Yu L, Li J, et al. Multiple triglyceride-derived metabolic indices and incident cardiovascular outcomes in patients with type 2 diabetes and coronary heart disease. Cardiovasc Diabetol. 2024;23:359. https:\/\/doi.org\/10.1186\/s12933-024-02446-1.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"5683_CR18","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.3390\/ijerph19063237","volume":"19","author":"K Dimitriadis","year":"2022","unstructured":"Dimitriadis K, Narkiewicz K, Leontsinis I, et al. Acute effects of electronic and tobacco cigarette smoking on sympathetic nerve activity and blood pressure in humans. Int J Environ Res Public Health. 2022;19(6):3237. https:\/\/doi.org\/10.3390\/ijerph19063237.","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"5683_CR19","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/add.15703","volume":"117","author":"NL Benowitz","year":"2022","unstructured":"Benowitz NL, Liakoni E. Tobacco use disorder and cardiovascular health. Addiction. 2022;117(4):1128\u201338. https:\/\/doi.org\/10.1111\/add.15703.","journal-title":"Addiction"},{"issue":"9","key":"5683_CR20","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41569-024-01017-x","volume":"21","author":"NS Wilcox","year":"2024","unstructured":"Wilcox NS, Amit U, Reibel JB, et al. Cardiovascular disease and cancer: shared risk factors and mechanisms. Nat Rev Cardiol. 2024;21(9):617\u201331. https:\/\/doi.org\/10.1038\/s41569-024-01017-x.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"5683_CR21","doi-asserted-by":"publisher","first-page":"2570212","DOI":"10.1080\/10641963.2025.2570212","volume":"47","author":"J Wu","year":"2025","unstructured":"Wu J, Zhu X, Wu Q, Xiao F. Interdisciplinary collaborative care model combined with family empowerment in patients with comorbid hypertension and diabetes: a study on blood pressure\/glucose control and psychosocial adaptation based on the COM-B model. Clin Exp Hypertens. 2025;47(1):2570212. https:\/\/doi.org\/10.1080\/10641963.2025.2570212.","journal-title":"Clin Exp Hypertens"},{"issue":"1","key":"5683_CR22","doi-asserted-by":"publisher","first-page":"2402260","DOI":"10.1080\/10641963.2024.2402260","volume":"46","author":"L Yang","year":"2024","unstructured":"Yang L, Zhu X, Zhu J, Hu Z, Wang C, Luo H, et al. Gestational diabetes causes hyperactivity of the sympathetic nervous system and hypertension in adult mice offspring. Clin Exp Hypertens. 2024;46(1):2402260. https:\/\/doi.org\/10.1080\/10641963.2024.2402260.","journal-title":"Clin Exp Hypertens"},{"issue":"10285","key":"5683_CR23","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","volume":"397","author":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration","year":"2021","unstructured":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet. 2021;397(10285):1625\u201336. https:\/\/doi.org\/10.1016\/S0140-6736(21)00590-0.","journal-title":"Lancet"},{"key":"5683_CR24","doi-asserted-by":"publisher","first-page":"133554","DOI":"10.1016\/j.ijcard.2025.133554","volume":"438","author":"C Mann","year":"2025","unstructured":"Mann C, Braunwald E, Zelniker TA. Diabetic cardiomyopathy revisited: the interplay between diabetes and heart failure. Int J Cardiol. 2025;438:133554. https:\/\/doi.org\/10.1016\/j.ijcard.2025.133554.","journal-title":"Int J Cardiol"},{"issue":"3","key":"5683_CR25","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/1753-0407.13369","volume":"15","author":"Y Chen","year":"2023","unstructured":"Chen Y, Zhang Y, Wang Y, et al. Assessment of subclinical left ventricular systolic dysfunction in patients with type 2 diabetes: relationship with HbA1c and microvascular complications. J Diabetes. 2023;15(3):264\u201374. https:\/\/doi.org\/10.1111\/1753-0407.13369.","journal-title":"J Diabetes"},{"issue":"1","key":"5683_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000520909","volume":"12","author":"K Vijay","year":"2022","unstructured":"Vijay K, Neuen BL, Lerma EV. Heart failure in patients with diabetes and chronic kidney disease: challenges and opportunities. Cardiorenal Med. 2022;12(1):1\u201310. https:\/\/doi.org\/10.1159\/000520909.","journal-title":"Cardiorenal Med"},{"key":"5683_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12933-023-01898-1","volume":"22","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Zhao L, Lu Y, et al. Association between non-insulin-based insulin resistance indices and cardiovascular events in patients undergoing percutaneous coronary intervention: a retrospective study. Cardiovasc Diabetol. 2023;22:161. https:\/\/doi.org\/10.1186\/s12933-023-01898-1.","journal-title":"Cardiovasc Diabetol"},{"key":"5683_CR28","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12905-023-02788-0","volume":"24","author":"Y Gu","year":"2024","unstructured":"Gu Y, Han F, Xue M, et al. The benefits and risks of menopause hormone therapy for the cardiovascular system in postmenopausal women: a systematic review and meta-analysis. BMC Womens Health. 2024;24:60. https:\/\/doi.org\/10.1186\/s12905-023-02788-0.","journal-title":"BMC Womens Health"},{"key":"5683_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.pcad.2024.01.015","volume":"84","author":"F Gersh","year":"2024","unstructured":"Gersh F, O\u2019Keefe JH, Elagizi A, et al. Estrogen and cardiovascular disease. Prog Cardiovasc Dis. 2024;84:60\u20137. https:\/\/doi.org\/10.1016\/j.pcad.2024.01.015.","journal-title":"Prog Cardiovasc Dis"},{"issue":"5","key":"5683_CR30","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1210\/clinem\/dgab042","volume":"106","author":"CL Shufelt","year":"2021","unstructured":"Shufelt CL, Manson JE. Menopausal hormone therapy and cardiovascular disease: the role of formulation, dose, and route of delivery. J Clin Endocrinol Metab. 2021;106(5):1245\u201354. https:\/\/doi.org\/10.1210\/clinem\/dgab042.","journal-title":"J Clin Endocrinol Metab"},{"key":"5683_CR31","unstructured":"Feingold KR. The Effect of Endocrine Disorders on Lipids and Lipoproteins. In: Feingold KR, Adler RA, Ahmed SF, et al, editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2023. https:\/\/pubmed.ncbi.nlm.nih.gov\/28121116\/."},{"key":"5683_CR32","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12944-024-02055-7","volume":"23","author":"Y Gao","year":"2024","unstructured":"Gao Y, Wang M, Wang R, et al. The predictive value of the hs-CRP\/HDL-C ratio, an inflammation-lipid composite marker, for cardiovascular disease in middle-aged and elderly people: evidence from a large national cohort study. Lipids Health Dis. 2024;23:66. https:\/\/doi.org\/10.1186\/s12944-024-02055-7.","journal-title":"Lipids Health Dis"},{"issue":"10","key":"5683_CR33","first-page":"721","volume":"31","author":"HY Guan","year":"2023","unstructured":"Guan HY, Qin Y, Yu H, et al. Long-term variability of fasting plasma glucose and cardiovascular disease mortality risk in patients with type 2 diabetes mellitus: a prospective cohort study [J]. Chin J Prev Control Chronic Dis. 2023;31(10):721-726 731.","journal-title":"Chin J Prev Control Chronic Dis"},{"issue":"12","key":"5683_CR34","first-page":"1211","volume":"39","author":"RX Zhang","year":"2024","unstructured":"Zhang RX, Yan LX, Li ZH, et al. Cardiovascular disease burden attributable to high body mass index among adults in China, 1990\u20132021 [J]. Chin Circul J. 2024;39(12):1211\u20136.","journal-title":"Chin Circul J"},{"key":"5683_CR35","doi-asserted-by":"publisher","first-page":"1483468","DOI":"10.3389\/fendo.2024.1483468","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, Li H, Chen X, et al. Association between various insulin resistance indices and cardiovascular disease in middle-aged and elderly individuals: evidence from two prospectives nationwide cohort surveys. Front Endocrinol (Lausanne). 2024;15:1483468. https:\/\/doi.org\/10.3389\/fendo.2024.1483468.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5683_CR36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12944-025-02440-w","volume":"24","author":"E Russo","year":"2025","unstructured":"Russo E, Viazzi F, Pontremoli R, et al. Predictive value of TG\/HDL-C and GFR-adjusted uric acid levels on cardiovascular mortality: the URRAH study. Lipids Health Dis. 2025;24:21. https:\/\/doi.org\/10.1186\/s12944-025-02440-w.","journal-title":"Lipids Health Dis"},{"key":"5683_CR37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12933-024-02253-8","volume":"23","author":"G Li","year":"2024","unstructured":"Li G, Huang J, Wang J, et al. Association between the triglyceride-glucose index and subclinical left ventricular systolic dysfunction in obese patients. Cardiovasc Diabetol. 2024;23:161. https:\/\/doi.org\/10.1186\/s12933-024-02253-8.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"5683_CR38","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12933-023-02050-9","volume":"22","author":"L Na","year":"2023","unstructured":"Na L, Cui W, Li X, et al. Association between the triglyceride-glucose index and left ventricular global longitudinal strain in patients with coronary heart disease in Jilin province, China: a cross-sectional study. Cardiovasc Diabetol. 2023;22(1):321. https:\/\/doi.org\/10.1186\/s12933-023-02050-9.","journal-title":"Cardiovasc Diabetol"},{"key":"5683_CR39","doi-asserted-by":"publisher","unstructured":"Cassano V, D\u2019Arrigo G, Gori M, et al. Possible correlation between triglyceride\/HDL ratio and subclinical myocardial damage in patients with cardiovascular risk factors. Diabetes Res Clin Pract. 2025;228 https:\/\/doi.org\/10.1016\/j.diabres.2025.112448.","DOI":"10.1016\/j.diabres.2025.112448"},{"issue":"1","key":"5683_CR40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12933-023-01762-2","volume":"22","author":"B Che","year":"2023","unstructured":"Che B, Zhong C, Zhang R, et al. Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data. Cardiovasc Diabetol. 2023;22(1):34. https:\/\/doi.org\/10.1186\/s12933-023-01762-2.","journal-title":"Cardiovasc Diabetol"},{"key":"5683_CR41","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","volume":"17","author":"V Ormazabal","year":"2018","unstructured":"Ormazabal V, Nair S, Elfeky O, et al. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17:122. https:\/\/doi.org\/10.1186\/s12933-018-0762-4.","journal-title":"Cardiovasc Diabetol"},{"key":"5683_CR42","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.2147\/DMSO.S404878","volume":"16","author":"X Zhang","year":"2023","unstructured":"Zhang X, Liu F, Li W, et al. Metabolic score for insulin resistance (METS-IR) predicts adverse cardiovascular events in patients with type 2 diabetes and ischemic cardiomyopathy. Diabetes Metab Syndr Obes. 2023;16:1283\u201395. https:\/\/doi.org\/10.2147\/DMSO.S404878.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"5683_CR43","doi-asserted-by":"publisher","first-page":"100391","DOI":"10.1016\/j.cpcardiol.2018.08.003","volume":"45","author":"VE Bianchi","year":"2020","unstructured":"Bianchi VE. Impact of nutrition on cardiovascular function. Curr Probl Cardiol. 2020;45(1):100391. https:\/\/doi.org\/10.1016\/j.cpcardiol.2018.08.003.","journal-title":"Curr Probl Cardiol"},{"issue":"4","key":"5683_CR44","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3390\/biom12040542","volume":"12","author":"M Khalid","year":"2022","unstructured":"Khalid M, Petroianu G, Adem A. Advanced glycation end products and diabetes mellitus: mechanisms and perspectives. Biomolecules. 2022;12(4):542. https:\/\/doi.org\/10.3390\/biom12040542.","journal-title":"Biomolecules"},{"issue":"2","key":"5683_CR45","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/ehf2.14224","volume":"10","author":"J Ke","year":"2022","unstructured":"Ke J, Pan J, Lin H, et al. Diabetic cardiomyopathy: a brief summary on lipid toxicity. ESC Heart Fail. 2022;10(2):776\u201390. https:\/\/doi.org\/10.1002\/ehf2.14224.","journal-title":"ESC Heart Fail"},{"issue":"7","key":"5683_CR46","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.3390\/ijms23073587","volume":"23","author":"K Nakamura","year":"2022","unstructured":"Nakamura K, Miyoshi T, Yoshida M, et al. Pathophysiology and treatment of diabetic cardiomyopathy and heart failure in patients with diabetes mellitus. Int J Mol Sci. 2022;23(7):3587. https:\/\/doi.org\/10.3390\/ijms23073587.","journal-title":"Int J Mol Sci"},{"issue":"14","key":"5683_CR47","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1113\/JP276747","volume":"598","author":"M Nakamura","year":"2020","unstructured":"Nakamura M, Sadoshima J. Cardiomyopathy in obesity, insulin resistance and diabetes. J Physiol. 2020;598(14):2977\u201393. https:\/\/doi.org\/10.1113\/JP276747.","journal-title":"J Physiol"},{"issue":"1","key":"5683_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02334-8","volume":"23","author":"M Duan","year":"2024","unstructured":"Duan M, Zhao X, Li S, et al. Metabolic score for insulin resistance (METS-IR) predicts all-cause and cardiovascular mortality in the general population: evidence from NHANES 2001-2018. Cardiovasc Diabetol. 2024;23(1):243. https:\/\/doi.org\/10.1186\/s12933-024-02334-8.","journal-title":"Cardiovasc Diabetol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05683-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05683-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05683-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T06:16:50Z","timestamp":1776665810000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-05683-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5683"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05683-2","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"9 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research Ethics Committee of Hunan Provincial People\u2019s Hospital (No. [2024]-50).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"332"}}